[Classification and treatment of torsades de pointes (TdP): a report of 11 cases]

K Z Mei1, A H Sun, B J Li

  • 1Department of Medicine, Red Cross Hospital, Guangzhou.

Zhonghua Nei Ke Za Zhi
|January 1, 1993
PubMed

Insights

This study analyzed 11 Torsades de Pointes (TdP) cases, finding magnesium sulfate effective for TdP with normal QT intervals but not long QT syndrome. Certain antiarrhythmics are contraindicated in long QT syndrome TdP.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Pharmacology

Context:

  • Torsades de Pointes (TdP) is a life-threatening ventricular arrhythmia.
  • Patients often have underlying conditions like coronary heart disease and electrolyte imbalances.
  • Previous treatment guidelines for TdP in specific patient groups are limited.

Purpose:

  • To analyze clinical characteristics and treatment outcomes of Torsades de Pointes (TdP).
  • To evaluate the efficacy of magnesium sulfate and other interventions in TdP management.
  • To identify contraindications for antiarrhythmic drug use in TdP patients with long QT syndrome.

Summary:

  • Eleven TdP cases were analyzed, divided into 9 with long QT syndrome and 2 with normal QT interval.
  • Common comorbidities included coronary heart disease, atrioventricular block, and hypokalemia.
  • Magnesium sulfate effectively treated TdP in 7/9 patients with normal QT intervals but was ineffective in long QT syndrome cases.
  • Class Ia and III antiarrhythmics were contraindicated in TdP with long QT syndrome but permissible in TdP with normal QT interval.

Impact:

  • Provides evidence-based treatment recommendations for TdP based on QT interval status.
  • Highlights the differential efficacy of magnesium sulfate in TdP management.
  • Informs clinical practice regarding antiarrhythmic drug selection in TdP patients.
  • Contributes to understanding TdP pathophysiology and management in complex cardiac conditions.

Related Concept Videos

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Dysrhythmias II: Classification of Tachyarrhythmias01:28

Dysrhythmias II: Classification of Tachyarrhythmias

Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...
Dysrhythmias III: Characteristics of Dysrhythmias01:29

Dysrhythmias III: Characteristics of Dysrhythmias

Dysrhythmias, also known as arrhythmias, are irregular heart rhythms that result from abnormal electrical activity in the heart, affecting its ability to circulate blood efficiently. Tachyarrhythmias, a subset of dysrhythmias, are characterized by abnormally fast heart rates exceeding 100 beats per minute. Here are some types of tachyarrhythmias with their distinct ECG features:Sinus Tachycardia:Sinus tachycardia presents a regular heart rhythm with an increased rate of 101-180 beats per minute.
Dysrhythmias V: Evaluating Dysrhythmias01:30

Dysrhythmias V: Evaluating Dysrhythmias

Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...